Monitoring the quality of conduct of clinical trials: A survey of current practices

Clinical Trials

Volumn 8, Issue 3, 2011, Pages 342-349

  Morrison, Briggs W ^a   Cochran, Chrissy J ^b   White, Jennifer Giangrande ^c   Harley, Joan ^d   Kleppinger, Cynthia F ^b   Liu, An ^e   Mitchel, Jules T ^f   Nickerson, David F ^a   Zacharias, Cynthia R ^g   Kramer, Judith M ^h   Neaton, James D ⁱ  

^a PFIZER INC   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c HOFFMANN LA ROCHE INC   (United States)

^d Training Extension/Pastor Consulting Inc   (United States)

^e Alquest   (United States)

^f Target Health Inc   (United States)

^g BRISTOL MYERS SQUIBB   (United States)

^h DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; GOVERNMENT; HUMAN; MEDICAL SOCIETY; PRIORITY JOURNAL; QUALITY CONTROL; QUESTIONNAIRE;

BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; DATA COLLECTION; HUMANS; QUALITY ASSURANCE, HEALTH CARE;

EID: 79960284830     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774511402703     Document Type: Article

References (8)

1. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice E6(R1). Available at: http://www.ich.org/LOB/media/MEDIA482.pdf (accessed 20 July 2010).
2. Eisenstein E, Collins R, Cracknell B, et al. Sensible approaches to reducing clinical trial costs. Clin Trials. 2008 ; 5: 75-84 (Pubitemid 351412376)
3. Baigent C, Harrell F, Buyse M, et al. Ensuring trial validity by data quality assurance and diversification of monitoring methods. Clin Trials. 2008 ; 5: 49-55 (Pubitemid 351412372)
4. Buyse M, George S, Evans S, et al. for the ISCB Subcommittee on Fraud. The role of biostatistics in prevention, detection, and treatment of fraud in clinical trials. Stat Med. 1999 ; 18: 3435-51 (Pubitemid 30041358)
5. Knatterud GL, Rockhold FW, George SL. Guidelines for quality assurance in multicenter trials: a position paper. Control Clin Trials. 1998 ; 19: 477-93 (Pubitemid 28448751)
6. US Food and Drug Administration. Inspections, Compliance, Enforcement, and Criminal Investigations: Warning Letters. Available at: http://www.fda.gov/ ICECI/EnforcementActions/WarningLetters/default.htm (accessed 20 July 2010).
7. Eisenstein EL, Lemons PW II, Tardiff BE, et al. Reducing the costs of phase III cardiovascular clinical trials. Am Heart J. 2005 ; 149: 482-88 (Pubitemid 40585412)
8. Usher RW. PhRMA BioResearch Monitoring Committee Perspective on acceptable approaches for clinical trial monitoring. DIA J. 2010 ; 44: 477-83